![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Georgetown University and Samaritan Sign Exclusive Licensing Agreement for Novel Treatment of Cushing's Syndrome
August 08, 2007 09:52 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Aug. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Chief Drug Development Officer to Present Lead Alzheimer's Drug At 12th IBC World Congress
August 02, 2007 10:05 ET
|
Samaritan Pharmaceuticals, Inc.
Focus Area: New and Emerging Therapeutic Targets for CNS
Topic: SP-233: A New and Novel Therapy With Protective Properties Against
the Neurotoxic Effects of Beta-Amyloid Peptide
LAS VEGAS,...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Exclusively Licenses Innovative Blood Diagnostic to Uncover Whether Breast Tumor is Cancer
July 30, 2007 10:22 ET
|
Samaritan Pharmaceuticals, Inc.
Blood Test Can Detect One Single Aggressive Cancer Cell Out of
Millions of Normal Blood Cells
Diagnostic Technology Thought to Detect Prostrate and Colon
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Therapeutics Signs Research Collaboration and Licensing Agreement With The Research Institute of McGill University Health Centre
July 25, 2007 10:01 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 25, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Samaritan Therapeutics, Canada, is pleased to announce it has signed a...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University
July 24, 2007 09:49 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive license agreement with...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Announces Positive Preliminary Results in a Phase IIb Study For Its Novel Oral HIV Entry Inhibitor
July 20, 2007 07:00 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, July 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce its novel oral HIV entry inhibitor SP-01A, being...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease
July 10, 2007 09:35 ET
|
Samaritan Pharmaceuticals, Inc.
Animal Study Confirms Caprospinol's (SP-233) Ability to Clear Brain
Plaque and Empower Rat Brain Cells to Recover Memory Function
In Vivo 'Proof of Concept' Study Proposes Direct Correlation...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Reorganizes Its Stock Structure
June 28, 2007 15:44 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life-saving drugs, announced today its Board of Directors has unanimously decided to...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Nationally Recognized M.D. Joins Samaritan Pharmaceuticals' Board of Directors
June 12, 2007 10:58 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 12, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs, announces Doug Bessert has decided for personal reasons to step...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan in Collaboration With UCSD Awarded NIH Grant for the Continued Development of Samaritan's Compounds to Suppress HIV Viral Replication and Prevent Neuronal Damage
June 07, 2007 09:40 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, June 7, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce the National Institutes of Health (NIH) has awarded a...